MONET® stands for Membrane Filtration Optimized Novel Extracorporeal Treatment.
Lipoprotein filtration with MONET® is used to reduce high molecular weight molecules such as:
The MONET® plasma fractionator contains a Fresenius Polysulfone® membrane, enhanced for use in lipoprotein filtration.
The membrane has the same excellent biocompatibilities as other Fresenius filters and is the result of our continuous product improvement procedures.
During lipoprotein filtration, venovenous or AV fistula access can be used. The procedure consists of two steps: In step one, the plasma is separated from whole blood by plasma filtration or centrifugation. In step two, the plasma is passed through a second filter, the MONET® plasma fractionator. MONET® retains high-molecular components, such as:
Finally, the purified plasma is combined again with the whole blood and returned to the patient.
MONET® can be carried out with:
1. Julius U et al.; Therapeutic Apheresis and Dialysis Apr. 2013; 17(2): 179–84.
2. Julius U et al.; Atherosclerosis Supplements May 2015; 18: 95–102